Journal
Blood Advances
Publication Date
12-24-2024
Volume
8
Issue
24
First Page
6248
Last Page
6256
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2024013687
Rights and Permissions
Uy GL, Pullarkat V, Baratam P, Stuart RK, Walter RB, Winer ES, Wang Q, Faderl S, Chakravarthy D, Menno D, Cheung RS, Lin TL. Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy. Blood Adv. 2024 Dec 24;8(24):6248-6256. doi: 10.1182/bloodadvances.2024013687. © 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Uy, Geoffrey L; Pullarkat, Vinod; Baratam, Praneeth; Stuart, Robert K; Walter, Roland B; Winer, Eric S; Wang, Qi; Faderl, Stefan; Chakravarthy, Divya; Menno, Diane; Cheung, Ronald S; and Lin, Tara L, "Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy." Blood Advances. 8, 24. 6248 - 6256. (2024).
https://digitalcommons.wustl.edu/oa_4/4546
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
